Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex J Brown

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?Alex J Brown
Molecular Aspects of Medicine|June 17, 2008
Vitamin D analogs: therapeutic applications and mechanisms for selectivityAlex J Brown, Eduardo Slatopolsky
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney diseaseAlex J Brown, Eduardo Slatopolsky
Blood Purification|January 23, 2002
Vitamin D analogs for the treatment of secondary hyperparathyroidismEduardo Slatopolsky, Alex J Brown
Journal of Cellular Biochemistry|February 22, 2011
Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolismCynthia S Ritter, Alex J Brown
Treatments in Endocrinology|April 19, 2005
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidismAlex J Brown, Daniel W Coyne
Calcified Tissue International|September 14, 2011
The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolismAlex J Brown, Cynthia S Ritter
Journal of Molecular Endocrinology|December 21, 2010
Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptorCynthia S Ritter, Alex J Brown
Kidney International|June 16, 2012
Bioavailable vitamin D in chronic kidney diseaseAlex J Brown, Daniel W Coyne
The Journal of Laboratory and Clinical Medicine|May 29, 2002
Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transportAlex J Brown, Jane Finch, Eduardo Slatopolsky
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?Alex J Brown
Molecular Aspects of Medicine|June 17, 2008
Vitamin D analogs: therapeutic applications and mechanisms for selectivityAlex J Brown, Eduardo Slatopolsky
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney diseaseAlex J Brown, Eduardo Slatopolsky
Blood Purification|January 23, 2002
Vitamin D analogs for the treatment of secondary hyperparathyroidismEduardo Slatopolsky, Alex J Brown
Journal of Cellular Biochemistry|February 22, 2011
Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolismCynthia S Ritter, Alex J Brown
Treatments in Endocrinology|April 19, 2005
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidismAlex J Brown, Daniel W Coyne
Calcified Tissue International|September 14, 2011
The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolismAlex J Brown, Cynthia S Ritter
Journal of Molecular Endocrinology|December 21, 2010
Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptorCynthia S Ritter, Alex J Brown
Kidney International|June 16, 2012
Bioavailable vitamin D in chronic kidney diseaseAlex J Brown, Daniel W Coyne
The Journal of Laboratory and Clinical Medicine|May 29, 2002
Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transportAlex J Brown, Jane Finch, Eduardo Slatopolsky
Pageof 5